32.84
-0.84 (-2.49%)
| Previous Close | 33.68 |
| Open | 32.06 |
| Volume | 9,152,634 |
| Avg. Volume (3M) | 21,766,301 |
| Market Cap | 7,601,070,592 |
| Price / Earnings (Forward) | 58.82 |
| Price / Sales | 3.98 |
| Price / Book | 19.28 |
| 52 Weeks Range | |
| Earnings Date | 10 Aug 2026 |
| Profit Margin | 9.21% |
| Operating Margin (TTM) | 10.12% |
| Diluted EPS (TTM) | 0.680 |
| Quarterly Revenue Growth (YOY) | 110.70% |
| Quarterly Earnings Growth (YOY) | 344.70% |
| Total Debt/Equity (MRQ) | 11.54% |
| Current Ratio (MRQ) | 1.59 |
| Operating Cash Flow (TTM) | 334.34 M |
| Levered Free Cash Flow (TTM) | 213.45 M |
| Return on Assets (TTM) | 10.76% |
| Return on Equity (TTM) | 36.79% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Mixed | Bullish |
| Drug Manufacturers - Specialty & Generic (Global) | Mixed | Mixed | |
| Stock | Hims & Hers Health, Inc. | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | -1.5 |
| Price Volatility | 2.0 |
| Technical Moving Averages | -1.5 |
| Technical Oscillators | 0.5 |
| Average | -0.13 |
|
Hims & Hers Health Inc operates telehealth platforms, providing access to treatments for various chronic conditions, including those related to sexual health, hair loss, hormone health, weight loss, dermatology, and mental health, as well as services such as comprehensive laboratory testing. The company connects patients to licensed healthcare professionals who can prescribe medications, with prescriptions fulfilled online through licensed pharmacies. In addition, it offers access to various non-prescription health and wellness products. Through the Hims & Hers mobile applications, the company also offers access to educational programs, wellness content, community support, and other services that promote lifelong health and wellness. Geographically, it derives maximum revenue from the USA. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Small Growth |
| % Held by Insiders | 11.13% |
| % Held by Institutions | 82.47% |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 11 Jul 2026 | CNBC | A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss |
| 07 Jun 2026 | CNBC | Harry's and Coterie owner Mammoth Brands has ambitions to be the next CPG giant |
| 21 Apr 2026 | CNBC | Amazon launches GLP-1 weight loss program, promising 'fast, convenient' access |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |